Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

BioNexus Gene Lab (BGLC) Interest Expenses (2021 - 2025)

BioNexus Gene Lab's Interest Expenses history spans 5 years, with the latest figure at $3272.0 for Q4 2025.

  • Quarterly results put Interest Expenses at $3272.0 for Q4 2025, down 43.7% from a year ago — trailing twelve months through Dec 2025 was $19542.0 (down 7.59% YoY), and the annual figure for FY2025 was $19542.0, down 7.59%.
  • Interest Expenses for Q4 2025 was $3272.0 at BioNexus Gene Lab, down from $6482.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $6482.0 in Q3 2025 to a low of -$4762.0 in Q4 2022.
  • The 5-year median for Interest Expenses is $3448.0 (2021), against an average of $2092.9.
  • Peak annual rise in Interest Expenses hit 305.55% in 2023, while the deepest fall reached 231.18% in 2023.
  • Year by year, Interest Expenses stood at -$3986.0 in 2021, then fell by 19.47% to -$4762.0 in 2022, then skyrocketed by 187.84% to $4183.0 in 2023, then surged by 38.94% to $5812.0 in 2024, then crashed by 43.7% to $3272.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $3272.0, $6482.0, and $4879.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.